Lista de obras - Giles Robinson - Dominio Público Uruguay

A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors

artículo científico publicado en 2017

A mouse model of the most aggressive subgroup of human medulloblastoma

artículo científico publicado en 2012

Advances in the classification of pediatric brain tumors through DNA methylation profiling: From research tool to frontline diagnostic

scientific article published on 26 September 2018

Atypical teratoid/rhabdoid tumor (ATRT) arising from the 3rd cranial nerve in infants: a clinical-radiological entity?

artículo científico publicado en 2015

Challenges to curing primary brain tumours

scientific article published on 01 August 2019

Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss

artículo científico publicado en 2015

Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy.

artículo científico publicado en 2014

Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.

artículo científico publicado en 2013

Corrigendum: Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss

artículo científico publicado en 2015

DNA methylation-based classification of central nervous system tumours.

artículo científico publicado en 2018

Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections

artículo científico publicado en 2014

Development of Molecularly Targeted Therapies to Treat Pediatric Malignancies.

artículo científico

EMBR-15. DIAGNOSTIC RE-EVALUATION AND POOLED CLINICAL DATA ANALYSIS OF PATIENTS WITH PREVIOUS DIAGNOSIS OF CNS-PNET

Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma

artículo científico publicado en 2014

Exposure-Toxicity Association of Cyclophosphamide and Its Metabolites in Infants and Young Children with Primary Brain Tumors: Implications for Dosing

scientific article published on 03 December 2019

FDG-PET CT in the evaluation of primary and secondary pancreatic malignancies

artículo científico publicado en 2018

Germline Elongator mutations in Sonic Hedgehog medulloblastoma

scientific article published on 01 April 2020

Germline GPR161 Mutations Predispose to Pediatric Medulloblastoma

artículo científico publicado en 2019

Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor.

artículo científico publicado en 2017

MBCL-44. THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (iMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07)

MBRS-34. MOLECULAR CHARACTERIZATION OF RECURRENT MEDULLOBLASTOMA REVEALS AN UNEXPECTEDLY HIGH INCIDENCE OF SECONDARY MALIGNANCY.

artículo científico publicado en 2018

Medulloblastoma

scientific article published on 14 February 2019

Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.

artículo científico publicado en 2013

Medulloblastoma-translating discoveries from the bench to the bedside

artículo científico publicado en 2014

Medulloblastoma: advances and challenges. ⬇️

artículo científico publicado en 2011

Medulloblastomics revisited: biological and clinical insights from thousands of patients

scientific article published on 09 December 2019

Medulloblastomics: the end of the beginning

scientific article published on December 2012

Non-Malignant Cerebrospinal Fluid Ascites in a Patient with Atypical Teratoid Rhabdoid Tumor

artículo científico publicado en 2017

Novel mutations target distinct subgroups of medulloblastoma.

artículo científico publicado en 2012

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)

artículo científico publicado en 2021

Ovulation induction and oocyte retrieval for fertility preservation in young adolescents newly diagnosed with medulloblastoma: a case series

artículo científico publicado en 2018

PNR-33MOLECULAR RE-EVALUATION OF INSTITUTIONALLY DIAGNOSED CNS-PNETS: CLINICAL CONSEQUENCES OF CONFINED DIAGNOSTIC GROUPS.

artículo científico publicado en 2016

Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma

artículo científico publicado en 2021

Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastoma

artículo científico publicado en 2014

Population Pharmacokinetics of Oral Topotecan in Infants and Very Young Children with Brain Tumors Demonstrates a Role of ABCG2 rs4148157 on the Absorption Rate Constant

artículo científico publicado en 2016

Preclinical studies of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in pediatric brain tumors

artículo científico publicado en 2015

Reoperation for Medulloblastoma Prior to Adjuvant Therapy.

artículo científico publicado en 2018

Reply to 'Assembling the brain trust: the multidisciplinary imperative in neuro-oncology'

artículo científico publicado en 2019

Resolving medulloblastoma cellular architecture by single-cell genomics

artículo científico publicado en 2019

Review: developmental origins of neural tumours: old idea, new approaches.

artículo científico

Risk stratification of childhood medulloblastoma in the molecular era: the current consensus

artículo científico publicado en 2016

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial

scientific article published on 16 May 2018

Role of MYC in Medulloblastoma.

artículo científico publicado en 2013

Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes

scientific article published on 10 May 2019

Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.

artículo científico publicado en 2018

Subtypes of medulloblastoma have distinct developmental origins

artículo científico publicado en 2010

The whole-genome landscape of medulloblastoma subtypes

artículo científico publicado en 2017

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.

artículo científico publicado en 2015

Zeb1 controls neuron differentiation and germinal zone exit by a mesenchymal-epithelial-like transition.

artículo científico publicado en 2016

mTORC1-Mediated Inhibition of 4EBP1 Is Essential for Hedgehog Signaling-Driven Translation and Medulloblastoma.

artículo científico publicado en 2017

Lista de obras de Giles Robinson

A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors

A mouse model of the most aggressive subgroup of human medulloblastoma

Advances in the classification of pediatric brain tumors through DNA methylation profiling: From research tool to frontline diagnostic

Atypical teratoid/rhabdoid tumor (ATRT) arising from the 3rd cranial nerve in infants: a clinical-radiological entity?

Challenges to curing primary brain tumours

Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss

Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy.

Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.

Corrigendum: Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss

DNA methylation-based classification of central nervous system tumours.

Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections

Development of Molecularly Targeted Therapies to Treat Pediatric Malignancies.

EMBR-15. DIAGNOSTIC RE-EVALUATION AND POOLED CLINICAL DATA ANALYSIS OF PATIENTS WITH PREVIOUS DIAGNOSIS OF CNS-PNET

Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma

Exposure-Toxicity Association of Cyclophosphamide and Its Metabolites in Infants and Young Children with Primary Brain Tumors: Implications for Dosing

FDG-PET CT in the evaluation of primary and secondary pancreatic malignancies

Germline Elongator mutations in Sonic Hedgehog medulloblastoma

Germline GPR161 Mutations Predispose to Pediatric Medulloblastoma

Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor.

MBCL-44. THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (iMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07)

MBRS-34. MOLECULAR CHARACTERIZATION OF RECURRENT MEDULLOBLASTOMA REVEALS AN UNEXPECTEDLY HIGH INCIDENCE OF SECONDARY MALIGNANCY.

Medulloblastoma

Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.

Medulloblastoma-translating discoveries from the bench to the bedside

Medulloblastoma: advances and challenges. ⬇️

Medulloblastomics revisited: biological and clinical insights from thousands of patients

Medulloblastomics: the end of the beginning

Non-Malignant Cerebrospinal Fluid Ascites in a Patient with Atypical Teratoid Rhabdoid Tumor

Novel mutations target distinct subgroups of medulloblastoma.

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)

Ovulation induction and oocyte retrieval for fertility preservation in young adolescents newly diagnosed with medulloblastoma: a case series

PNR-33MOLECULAR RE-EVALUATION OF INSTITUTIONALLY DIAGNOSED CNS-PNETS: CLINICAL CONSEQUENCES OF CONFINED DIAGNOSTIC GROUPS.

Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma

Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastoma

Population Pharmacokinetics of Oral Topotecan in Infants and Very Young Children with Brain Tumors Demonstrates a Role of ABCG2 rs4148157 on the Absorption Rate Constant

Preclinical studies of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in pediatric brain tumors

Reoperation for Medulloblastoma Prior to Adjuvant Therapy.

Reply to 'Assembling the brain trust: the multidisciplinary imperative in neuro-oncology'

Resolving medulloblastoma cellular architecture by single-cell genomics

Review: developmental origins of neural tumours: old idea, new approaches.

Risk stratification of childhood medulloblastoma in the molecular era: the current consensus

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial

Role of MYC in Medulloblastoma.

Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes

Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.

Subtypes of medulloblastoma have distinct developmental origins

The whole-genome landscape of medulloblastoma subtypes

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.

Zeb1 controls neuron differentiation and germinal zone exit by a mesenchymal-epithelial-like transition.

mTORC1-Mediated Inhibition of 4EBP1 Is Essential for Hedgehog Signaling-Driven Translation and Medulloblastoma.